Senior Scientist, Computational Biology & Data Infrastructure
About the role
OVERVIEW
Kingdom is building the world's first AI-native functional ingredients company, with $40M+ in venture funding from top investors. We've pioneered Superculture® ingredients: an entirely new class of clinically validated postbiotics, made from natural microbes, that target the root causes of unmet health needs for people and pets. We’re launching one new clinically backed ingredient every year.
We're looking for a high-performing Senior Scientist, Computational Biology & Data Infrastructure, to join our small but mighty team. This is an AI-native science role: you'll own the computational backbone of Kingdom's research (the microbial genomics and AI-compatible data infrastructure that every wet-lab program depends on) and ship custom and integrated LLM tooling to automate and accelerate our work. We want a PhD-level computational biologist (or related area) who applies rigorous scientific judgment to genomic analysis, biobank strategy, and statistical methods, and is equally excited to build the systems that let everyone move faster. Fundamentally, this is a science role, with success measured by the integrity of our data, the insights our data infrastructure unlocks, and the AI tooling we deploy across our scientific platform.
Our edge starts with one of the world's largest, most diverse biobanks of proprietary microbial strains, sourced from natural foods and environmental sources. On top of it, we've built a scientific platform spanning ingredient discovery, clinical trials, and manufacturing scale-up that lets our small team outcompete companies 100X+ our size.
We're actively selling Superculture® Pet Oral and Superculture® Pet Immune to pet food and supplement brands. Less than a year in market, our ingredients are already powering dozens of products from leading pet brands, with overwhelmingly positive customer reception. One in three product launches using our ingredients has earned a #1 New Release on Amazon, and nine in ten of our customers are launching additional products with us.
Now we're scaling rapidly. We'll launch our first Superculture ingredient for humans later this year, opening up an entirely new market. And we're expanding internationally, starting with the EU/UK and China, with Australia/New Zealand and other APAC markets on the horizon.
